The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Abstract
Gut microbial metabolites, SCFAs, were related with the occurrence and development of Parkinson's disease (PD). But the effects of different short-chain fatty acids (SCFAs) on PD and involving mechanisms are still undefined. In this study we evaluate the effects of three dominant SCFAs (acetate, propionate and butyrate) on motor damage, dopaminergic neuronal degeneration and underlying neuroinflammation related mechanisms in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice. High (2.0 g/kg) or low doses (0.2 g/kg) of sodium acetate (NaA), sodium propionate (NaP) or sodium butyrate (NaB) were gavaged into PD mice for 6 weeks. High doses of NaA reduced the turning time of PD mice. NaB significantly reduced the turning and total time in pole test, and increased the average velocity in open field test when compared with PD mice, indicating the most effective alleviation of PD-induced motor disorder. Low and high doses of NaB significantly increased the content of tyrosine hydroxylase (TH) by 12.3% and 20.2%, while reduced α-synuclein activation by 159.4% and 132.7% in the substantia nigra pars compacta (SNpc), compared with PD groups. Butyrate reached into the midbrain SNpc and suppressed microglia over-activation. It inhibited the levels of pro-inflammatory factors (IL-6, IL-1β and TNF-α) (P < 0.01) and iNOS. Besides, butyrate inhibited the activation of NF-κB and MAPK signaling pathways in the SNpc region. Consequently, sodium butyrate could inhibit neuroinflammation and alleviate neurological damage of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, studies have demonstrated the neuroprotective effects of sodium butyrate in MPTP-induced PD mice by attenuating microglial reactivity via the inhibition of TLR4/MyD88/NF-κB and MAPK signaling pathway.319–321”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [319]
In the citing paper
“NaB can improve motor symptoms, neuronal loss, and neuroinflammation in MPTP-induced PD mice [23,24,25].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [23]
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Butyrate: A Double-Edged Sword for Health?
Liu, H., Wang, J., He, T., Becker, S. R., Zhang, G., Li, D., & Ma, X. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx009 · Cited by 1,185
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Sun, M., Wu, W. H., Liu, Z., & Cong, Y. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1242-9 · Cited by 1,103
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
Fox, S. H., Katzenschlager, R., Lim, S., Barton, B. R., de Bie, R. M. A., Seppi, K., Coelho, M. M., & Sampaio, C. (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,009
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3549 · Cited by 914
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 654
Norden, D. M., Trojanowski, P. J., Villanueva, E., Navarro, E., & Godbout, J. P. (2015) · Glia · doi:10.1002/glia.22930 · Cited by 623
Wang, M., Wichienchot, S., He, X., Fu, X., Huang, Q., & Zhang, B. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.03.005 · Cited by 519
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Fleming, S. M., Salcedo, J. D., Fernagut, P., Rockenstein, E. M., Masliah, E., Levine, M. S., & Chesselet, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3080-04.2004 · Cited by 477
Ghosh, A., Roy, A., Liu, X., Kordower, J. H., Mufson, E. J., Hartley, D. M., Ghosh, S., Mosley, R. L., Gendelman, H. E., & Pahan, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704908104 · Cited by 438
Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice
Yang, X., Yu, D., Xue, L., Li, H., & Du, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.001 · Cited by 407
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai
Zhang, Z., Román, G. C., Hong, Z., Wu, C.-B., Qu, Q.-M., Huang, J.-B., Zhou, B., Geng, Z.-P., Wu, J.-X., Wen, H.-B., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17909-4 · Cited by 398
Gut microbial molecules in behavioural and neurodegenerative conditions
Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379
Johnson, M., & Bobrovskaya, L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.12.002 · Cited by 344
Prospective study of dietary pattern and risk of Parkinson disease
Gao, X., Chen, H., Fung, T. T., Logroscino, G., Schwarzschild, M. A., Hu, F. B., & Ascherio, A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1486 · Cited by 340
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Caputi, V., & Giron, M. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061689 · Cited by 338
Microbiota composition and metabolism are associated with gut function in Parkinson's disease
Cirstea, M. S., Yu, A. C., Golz, E., Sundvick, K., Kliger, D., Radisavljevic, N., Foulger, L. H., Mackenzie, M., Huan, T., Finlay, B. B., et al. (2020) · Movement Disorders · doi:10.1002/mds.28052 · Cited by 326
Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314
Altered brain-gut axis in autism: comorbidity or causative mechanisms
Mayer, E. A., Padua, D., & Tillisch, K. (2014) · BioEssays · doi:10.1002/bies.201400075 · Cited by 304
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai
ZHANG, Z., Román, G. C., Hong, Z., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70801-1 · Cited by 302
Nonpharmacological treatments for patients with Parkinson's disease
Bloem, B. R., de Vries, N. M., & Ebersbach, G. (2015) · Movement Disorders · doi:10.1002/mds.26363 · Cited by 273
p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Mogi, M., Kondo, T., Mizuno, Y., & Nagatsu, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.003 · Cited by 252
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
Antonini, A. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s6456 · Cited by 251
Elamin, E. E., Masclee, A., Jan, D., Pieters, H., & Jonkers, D. M. A. E. (2013) · Journal of Nutrition · doi:10.3945/jn.113.179549 · Cited by 237
Gut microbiota: Implications in Parkinson's disease
Parashar, A., & Malairaman, U. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.002 · Cited by 237
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Klegeris, A., Pelech, S., Giasson, B. I., Maguire, J., Zhang, H., McGeer, E. G., & McGeer, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.013 · Cited by 227
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
Surmeier, D. J., Guzmán, J. N., & Sánchez-Padilla, J. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.003 · Cited by 224
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205
Yamawaki, Y., Yoshioka, N., Nozaki, K., Ito, H., Oda, K., Harada, K., Shirawachi, S., Asano, S., Aizawa, H., Yamawaki, S., et al. (2018) · Brain Research · doi:10.1016/j.brainres.2017.12.004 · Cited by 204
St. Laurent, R., O’Brien, L. M., & Ahmad, S. T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.037 · Cited by 199
Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE
Ziehn, M. O., Avedisian, A., Tiwari-Woodruff, S., & Voskuhl, R. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.6 · Cited by 190
Paiva, I., Pinho, R., Pavlou, M. A., Hennion, M., Wales, P., Schütz, A.-L., Rajput, A., Szegő, É. M., Kerimoglu, C., Gerhardt, E., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx114 · Cited by 185
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
Travagli, R. A., Browning, K. N., & Camilleri, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0339-z · Cited by 181
Levodopa therapy for Parkinson disease
LeWitt, P. A., & Fahn, S. (2016) · Neurology · doi:10.1212/wnl.0000000000002509 · Cited by 179
Shultz, S. R., MacFabe, D. F., Martin, S. P., Jackson, J., Taylor, R., Boon, F. H., Ossenkopp, K., & Cain, D. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.023 · Cited by 159
Oxidative Stress and Parkinson's Diseasea
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 154
Sharma, S., Taliyan, R., & Singh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.052 · Cited by 142
Plasma Short‐Chain Fatty Acids in Patients With Parkinson's Disease
Shin, C., Lim, Y., Lim, H., & Ahn, T. (2020) · Movement Disorders · doi:10.1002/mds.28016 · Cited by 116
Paknahad, Z., Sheklabadi, E., Derakhshan, Y., Bagherniya, M., & Chitsaz, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102366 · Cited by 113
Novel formulations and modes of delivery of levodopa
Poewe, W. H., & Antonini, A. (2014) · Movement Disorders · doi:10.1002/mds.26078 · Cited by 108
French, S. A., Harnack, L., Toomey, T. L., & Hannan, P. J. (2007) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-4-52 · Cited by 68
Fan, H., Wu, P., Zhang, L., Hu, Z., Wang, W., Guan, X., Luo, H., Ni, M., Yang, J., Li, M., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6022 · Cited by 66
Neurodegenerative signaling factors and mechanisms in Parkinson's pathology
Goswami, P., Joshi, N., & Singh, S. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.06.008 · Cited by 51
Diet and medical foods in Parkinson’s disease
Lange, K. W., NAKAMURA, Y., Chen, N., Guo, J., Kanaya, S., Lange, K. M., & Li, S. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.03.006 · Cited by 43
Bavafa-Valenlia, K., Morshedi, M., Saghafi‐Asl, M., Shahabi, P., & Abbasi, M. M. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.069 · Cited by 40
Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking
Sharer, J. D., Leon‐Sarmiento, F. E., Morley, J. F., Weintraub, D. A., & Doty, R. L. (2014) · Movement Disorders · doi:10.1002/mds.26126 · Cited by 36
Chen, J. J., & Wilkinson, J. R. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011406279 · Cited by 34
von Twickel, A., Kowatschew, D., Saltürk, M., Schauer, M., Robertson, B., Korsching, S. I., Walkowiak, W., Grillner, S. E., & Pérez‐Fernández, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.01.004 · Cited by 34
PBPK/PD assessment for Parkinson’s disease risk posed by airborne pesticide paraquat exposure
Cheng, Y., Chou, W., Yang, Y., Huang, C., How, C. M., Chen, S., Chen, W., Hsieh, N., Lin, Y., You, S., et al. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0875-4 · Cited by 27
Huang, W., Xu, Y., Zhang, Y., Zhang, P., Zhang, Q., Zhang, Z., & Xu, F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14774 · Cited by 26
Kim, S. J., Ryu, M. J., Han, J., Jang, Y., Kim, J., Lee, M. J., Ryu, I., Ju, X., Oh, E., Chung, W., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.017 · Cited by 23
Tan, X., Zhang, L., Zhu, H., Qin, J., Tian, M., Dong, C., Li, H., & Jin, G. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.019 · Cited by 21
Peng, Z., Luchtman, D. W., Wang, X., Zhang, Y., & Song, C. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.024 · Cited by 19
Research works printed but not linked: 1
- Cao, 2006, Mechanism of over-activation in direct pathway mediated by dopamine D₁ receptor in rats with levodopa-induced dyskinesia. Neurosci, Bull, 22, 159
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 212
Self-citationGut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
Self-citationKalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103092 · Cited by 185
Cao, Q., Shen, M., Li, R., Liu, Y., Zeng, Z., Zhou, J., Niu, D., Zhang, Q., Wang, R., Yao, J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03454-y · Cited by 138
Metadata
- Authors
- Hou, Y., Li, X., Liu, C., Zhang, M., Zhang, X., Ge, S., & Zhao, L.
- Affiliations
- Beijing Advanced Innovation Center for Food Nutrition and Human Health (CN)
- China Agricultural University (CN)
- Beijing Technology and Business University (CN)
- Corresponding author
- Zhao, Liang
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 150
- Pages
- 111376
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W3159598422
- Cited by
- 101
- References
- 63
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 28 · 2023: 15 · 2022: 13 · 2021: 5
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (32072196)
- Beijing Science and Technology Planning Project (Z181100009318005)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- short-chain fatty acids, Parkinson's disease, MPTP-induced neurotoxicity, sodium butyrate, sodium acetate, sodium propionate, neuroprotection, dopaminergic neuron loss, substantia nigra pars compacta, neuroinflammation, microglial activation, alpha-synuclein, tyrosine hydroxylase, NF-κB signaling, MAPK signaling, gut microbiota metabolites, motor impairment
- MeSH terms
- Animals, Disease Models, Animal, Fatty Acids, Volatile, Mice, Inbred C57BL, Parkinson Disease, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroprotective Agents, MPTP Poisoning, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
